Editorial Policies

Focus and Scope

Pharmaciana publishes original article in the all scopes of Pharmaceutical Science such as Pharmaceutics, Biopharmaceutics, Drug Delivery System, Physical Pharmacy, Chemical Pharmacy, Pharmaceutical Technology, Pharmaceutical Microbiology and Biotechnology, Pharmacology and Toxicology, Pharmacokinetics, Pharmaceutical Chemistry, Pharmaceutical Biology, Community and Clinical Pharmacy, Regulatory Affairs and Management Pharmacy, and  Alternative Medicines.


Section Policies

Analytical Pharmacy and Medicinal Chemistry

  • Kenny Chitcholtan
  • Dadan Hermawan, M.Si., Ph.D
  • Irwandi Jaswir
  • Nurkhasanah Mahfudh,M.Si.,Apt
  • Achmad Mursyidi
  • Iin Narwanti, MSc.
  • Abdul Rohman, Prof., Dr., MSi., Apt.
Checked Open Submissions Checked Indexed Checked Peer Reviewed


  • Moch. Bachri
  • Zullies Ikawati, Prof., Dr., Apt
  • Sugiyanto Sugiyanto, Prof., Dr., SU., Apt
  • Woro Supadmi, M.Sc, Apt
  • Sapto Yuliani, MP
Checked Open Submissions Checked Indexed Checked Peer Reviewed

Clinical and Community Pharmacy

  • Akrom Akrom, Dr., M.Kes
  • Tri Andayani, Ph.D, Sp.FRS, Apt
  • Dyah Aryani Perwitasari
  • Faridah Baroroh, MSc., Apt.
  • Susan Candradewi, M.Sc., Apt
  • Keri Lestari Dandan, Dr., M.Si., Apt
  • Bob Wilffert
Checked Open Submissions Checked Indexed Checked Peer Reviewed

Pharmaceutics and Pharmaceutical Technology

  • Annas Binarjo, M.Sc.
  • Citra Edityaningrum, M.Si, Apt
  • Lannie Hadisoewignyo, Dr., M.Si., Apt
  • Akhmad Kharis Nugroho, Prof., Dr., M.Si, Apt
  • Nurkhasanah Mahfudh,M.Si.,Apt
  • Dr.Nining Sugihartini,M.Si., Apt
  • Anita Sukmawati, Ph.D., Apt.
  • Tedjo Yuwono, Apt.
Checked Open Submissions Checked Indexed Checked Peer Reviewed

Biology Pharmacy

  • Isnaeni Haryanto
  • Laela Nurani, MSi., Apt.
  • Sukanya Ph.D
  • Nina Salamah, M.Sc, Apt.
Checked Open Submissions Checked Indexed Checked Peer Reviewed

Peer Review Process

Every submitted paper will be initialized review by a Section Editor whether it is suitable for Pharmaciana's focus and scope or has a major methodological flaw and similarity score by using iThenticate. If the manuscript meets these requirements then the manuscript will be reviewed by a minimum of two reviewers and the review process uses a Single-Blind Peer Review.

Reviewing process will consider novelty, objectivity, method, scientific impact, conclusion, and references. The suggested decision will be evaluated in an editorial board meeting. Afterward, the editor will send a decision to the corresponding author.

Review Outcomes
Utilizing feedback from the peer review process, the Editor will make a final publication decision. The review process will take approximately 4 to 12 weeks. Decisions categories include:

  1. Decline Submission - The manuscripts will not be published, and authors will not have the opportunity to resubmit a revised version of the manuscript to Pharmaciana.
  2. Resubmit for Review - The submission needs to be re-worked, but it may be accepted with significant changes. However, It will require a second round of review.
  3. Revisions Required- Manuscripts will be published in Pharmaciana under the condition that minor/major modifications are made. An editor will review revisions to ensure necessary updates are made before publication.
  4. Accept Submission- Accepted manuscripts will be published in the current form, with no further modifications required.

Editing Stages

The Accepted manuscript will be continued to copyediting, layout editing, and proofreading before it is published.


Publication Frequency

This journal is published 3 times per year in March, July and November


Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.




Screening For Plagiarism

Plagiarism screening will be conducted by Pharmaciana Editorial Board using iThenticate. The papers submitted to Pharmaciana must have a similarity level of less than 20%. 


Abstracting and Indexing

Pharmaciana indexed by:



Publication Ethics and Publication Malpractice Statement

This statement clarifies ethical behaviour of all parties involved in the act of publishing an article in our journals, including the authors, the editors, the peer-reviewers and the publisher (Universitas Ahmad Dahlan). This statement is based on COPE’s Best Practice Guidelines for Journal Editors.

Ethical Guideline for Journal Publication
The publication of an article in a peer-reviewed Pharmaciana Journal is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the authors, the journal editors, the peer reviewers, the publisher and the society.  
Universitas Ahmad Dahlan (UAD) as publisher of this Journal takes its duties of guardianship over all stages of publishing extremely seriously and we recognize our ethical and other responsibilities. We are committed to ensuring that advertising, reprint or other commercial revenue has no impact or influence on editorial decisions. In addition, the UAD, and Editorial Board will assist in communications with other journals and/or publishers where this is useful and necessary.

Publication decisions

The editors of Pahrmaciana are responsible for deciding which of the articles submitted to the journal should be published. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editors may confer with other editors or reviewers in making this decision.

Fair play

An editor at any time evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.


The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

Disclosure and conflicts of interest

Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.

Duties of Reviewers
Contribution to Editorial Decisions
Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper.


Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.

Standards of Objectivity

Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Acknowledgement of Sources
Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and Conflict of Interest
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Duties of Authors
Reporting standards
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable.

Data Access and Retention
Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Originality and Plagiarism
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.

Multiple, Redundant or Concurrent Publication

An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.

Acknowledgement of Sources
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.

Authorship of the Paper

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Hazards and Human or Animal Subjects
If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.

Disclosure and Conflicts of Interest

All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.


Witdrawal of Manuscripts

Author is not allowed to withdraw submitted manuscripts, because the withdrawal is waste of valuable resources that editors and referees spent a great deal of time processing submitted manuscript, money and works invested by the publisher.

If author still requests withdrawal of his/her manuscript when the manuscript is still in the peer-reviewing process, author will be punished with paying IDR 200.000 per manuscript, as withdrawal penalty to the publisher. However, it is unethical to withdraw a submitted manuscript from one journal if accepted by another journal. The withdrawal of manuscript after the manuscript is accepted for publication, author will be punished by paying  IDR 500 per manuscript. Withdrawal of manuscript is only allowed after withdrawal penalty has been fully paid to the Publisher.

If author don't agree to pay the penalty, the author and his/her affiliation will be blacklisted for publication in this journal. Even, his/her previously published articles will be removed from our online system.


Subscription (Hardcopy Order)

Would you like to receive a hard copy of our publications?

Pharmaciana has a liberal policy to allow the authors and readers to order the hardcopies of any particular number/issue or volume (bundle) of the journal. The hardcopy initiative is a print-on-demand and a not-for-profit initiative. A minimal fees is applied to cover the printing, handling, packaging and postal delivery of the journal volume. To keep the process simple,  Pharmacian pricing is uniformly applicable over all the volumes.

Price of an Issue :  IDR 150.000

The price is not included the packaging and postal delivery fees of the hardcopy to the address of the authors or subscribers (with Registered Mail standard).

Request for journal hardcopy can send an email to pharmaciana@pharm.uad.ac.id bearing the subject line "Request for hardcopy".



The papers published in the Pharmaciana will be considered to retract in the publication if:

  1. They have clear evidence that the findings are unreliable, either as a result of misconduct (e.g. data fabrication) or honest error (e.g. miscalculation or experimental error).
  2. The findings have previously been published elsewhere without proper cross-referencing and permission or justification (i.e. cases of redundant publication).
  3. It constitutes plagiarism.
  4. It reports unethical research.

The mechanism of retraction follows the Retraction Guidelines of Committee on Publication Ethics (COPE) which can be accessed at https://publicationethics.org.